← Leaderboards
Jason Rodencal
Stanford University
$78,678
Attributed
$78,678
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40.2K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$78,678 · 1
By mechanism
F31$78,678 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Edward I Solomon$24,141,500
- Eric Richard Gross$8,155,151
- Daria Mochly-Rosen$28,932,521
- Stephen Montgomery$23,593,399
- James P Collman$4,520,601
Others in their field
Other Emerging Leaders on “Drug Targeting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$47,265,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$38,850,978
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Research focus
Drug TargetingExperimental StudyAcyltransferaseAffectEndoplasmic ReticulumEnzymesAntioxidantsCancer CellCancer PatientCancer TherapyAntineoplastic AgentsCdk4 GeneCell DeathBiologicalCell MembraneCancer BiologyCellsCessation Of LifeClinical CandidateClinically SignificantClustered Regularly Interspaced Short Palindromic RepeatsC-TerminalCancer TypeGene Expression